ClinicalTrials.Veeva

Menu
S

Schuster Medical Research Institute | Sherman Oaks, CA

Research site
(Unclaimed)

Site insights

Top conditions

Top treatments

KarXT
Bapineuzumab
Cariprazine
BMS-820836
SEP-363856
Atogepant
Lasmiditan
Aripiprazole
MK-8189
Leuco-methylthioninium Bis(Hydromethanesulfonate)

Data sourced from clinicaltrials.gov

Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site

Active trials

2 of 33 total trials

A Long-Term Safety and Tolerability Extension Study Evaluating Atogepant for the Prevention of Chronic or Episodic Migraine

This study will evaluate the Long-Term Safety and Tolerability of Atogepant 60 mg daily for the Prevention of Migraine in Participants with Chronic o...

Active, not recruiting
Chronic Migraine
Episodic Migraine
Drug: Atogepant 60 mg

This is a Phase 3, multicenter, 56-week, outpatient, open-label (OL) study to evaluate the long-term safety, tolerability, and efficacy of KarXT in d...

Active, not recruiting
Schizophrenia
Drug: Xanomeline and Trospium Chloride Capsules

Trial sponsors

AbbVie logo
Janssen (J&J Innovative Medicine) logo
Karuna Therapeutics logo
Lilly logo
Otsuka logo
Allergan logo
Bristol-Myers Squibb (BMS) logo
T
Acadia Pharmaceuticals logo
B

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems